Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 30.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 61,346 shares of the company’s stock after purchasing an additional 14,411 shares during the period. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Trust were worth $2,284,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in BME. Janney Montgomery Scott LLC raised its holdings in shares of BlackRock Health Sciences Trust by 9.7% in the second quarter. Janney Montgomery Scott LLC now owns 38,475 shares of the company’s stock worth $1,403,000 after acquiring an additional 3,401 shares during the last quarter. Farther Finance Advisors LLC purchased a new position in BlackRock Health Sciences Trust in the 2nd quarter valued at about $75,000. Consolidated Portfolio Review Corp boosted its stake in shares of BlackRock Health Sciences Trust by 34.7% during the 2nd quarter. Consolidated Portfolio Review Corp now owns 38,879 shares of the company’s stock worth $1,418,000 after purchasing an additional 10,012 shares during the last quarter. HBK Sorce Advisory LLC raised its position in shares of BlackRock Health Sciences Trust by 27.1% in the second quarter. HBK Sorce Advisory LLC now owns 11,602 shares of the company’s stock valued at $423,000 after buying an additional 2,476 shares during the last quarter. Finally, Cypress Capital Management LLC WY purchased a new position in shares of BlackRock Health Sciences Trust during the second quarter valued at approximately $1,405,000.
BlackRock Health Sciences Trust Stock Down 0.2%
BME stock opened at $41.79 on Friday. The company has a 50 day moving average price of $40.93 and a two-hundred day moving average price of $38.27. BlackRock Health Sciences Trust has a one year low of $34.18 and a one year high of $42.46.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
